SAGE PRO

Home / Research / Hindustan Unilever Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

Hindustan Unilever Limited — Q2 FY27 Results Analysis

Volume-led growth is back

Published · Quarter Q2 FY27 · HINDUNILVR

Turnover₹18,071cr
USG15%
UVG7%
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Underlying growth

Sales15 % Q2 FY27
Volume7 % Q2 FY27
CHART 2

YoY growth, different bases

Underlying sales15 % YoY
EBITDA8 % YoY
PAT before exceptions9 % YoY
CHART 3

Underlying sales growth by segment

Home Care22 % USG
Beauty/Wellbeing16 % USG
Personal Care9 % USG
Foods9 % USG
ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Volume-led growth is back

Q2 turnover ₹18,071cr; underlying sales +15%, volume +7%.

Watch: WATCH margin conversion and clean PAT.

RESEARCH INSIGHT

Revenue strength did not fully reach EBITDA

Reported EBITDA +8% YoY versus 15% underlying sales growth.

Watch: Review cost/mix and margin.

RESEARCH INSIGHT

Home Care outperformed

Home Care USG 22% led by double-digit UVG, broad across fabric and household.

Watch: Watch volume resilience and pricing.

RESEARCH INSIGHT

Premium skin and hair care gained share of attention

Beauty & Wellbeing USG 16%, supported by premium innovation and double-digit volume.

Watch: Review promotional investment economics.

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

SAGE PRO | September quarter 2026 / Q2 FY2027 | 17 November 2026 | NSE: HINDUNILVR Stance: WATCH with constructive operating momentum. This seven-chapter research report uses Sage PRO's existing accepted September-quarter issuer presentation and earnings call. It is not a price-target forecast.

30-second investment take

Key takeaways

  • What is working. Hindustan Unilever delivered ₹18,071 crore turnover in the quarter ended 30 September 2026, with 15% underlying sales growth (USG) and 7% underlying volume growth (UVG).
  • This was management's strongest USG reading in 14 quarters.
  • Home Care and Beauty & Wellbeing grew faster than the group and volumes were broad-based.

What is risky. EBITDA grew 8%, slower than underlying sales, while the EBITDA margin was 22.6%. Commodity inflation, premiumization costs and channel investments mean the strong top line cannot automatically be converted into a matching profit rate. Personal Care and Foods grew only 9% on the issuer's underlying sales definition.

What valuation demands. The franchise is valued on durable volume-led profit growth, brand strength and cash generation rather than short-term promotional sales. A numeric target would require a verified dated price, sustainable margin assumptions and comparable financial data, so it is not invented here.

Fact-labelled Q2 dashboard

Company-reported measureQ2 FY27Basis
Turnover₹18,071 croreSeptember-quarter company turnover
Underlying sales growth15%Excludes acquisitions/disposals impact
Underlying volume growth7%Company's volume growth definition includes mix
EBITDA₹4,089 crore+8% YoY, company disclosure
EBITDA margin22.6%Within guided range
PAT before exceptional items₹2,795 crore+9% YoY
Reported PAT₹2,796 croreBroadly flat YoY; prior year included ₹273 crore one-off tax-related gains
H1 FY27 turnover₹35,255 croreSix months to September, not a single quarter
Interim dividend₹19/shareBoard declaration for FY27

Why it matters. Volume-led growth is returning, but margin and clean profit growth determine how much of that revenue expansion accrues to shareholders.

---

01 — Investment thesis: volume growth confirms demand, but margin discipline pays the bill

Key takeaways

  • HUL is primarily a portfolio of household and personal-consumption brands sold across general trade, modern trade, e-commerce and quick commerce.
  • Its scale creates advantages in distribution, sourcing and consumer recognition, but premium category mix, promotional intensity and commodity input costs determine the actual earnings quality.

The September quarter provided a stronger operating foundation than many preceding quarters: 7% UVG accompanied 15% USG, rather than a purely price-driven headline. Management highlighted the highest underlying sales growth in 14 quarters and broad-based gains across multiple categories.

The strategic question is whether higher volume is structural enough to support selective price increases and innovation investment. A company can show excellent underlying sales growth yet earn a smaller incremental profit margin if advertising, premium launches, commodity inflation or channel competition absorb the proceeds.

Bull thesis: a broader premium portfolio and more efficient distribution support persistent volumes, good brand margins and improving returns on reinvestment.

Counter-thesis: competitive pricing, retailer/channel economics and rising input costs make volume gains expensive; high-growth emerging categories consume resources before generating comparable contribution profit.

Investment test: the next two quarters' volume growth, EBITDA conversion and growth in PAT before exceptional items, not just net sales.

---

02 — Financial performance: distinguish clean growth from exceptional-item comparisons

Key takeaways

  • The company reported ₹18,071 crore turnover, 15% USG, 7% UVG, ₹4,089 crore EBITDA and 22.6% EBITDA margin for the September quarter.
  • These figures refer to the reporting period ending 30 September 2026; none is a forward estimate.

EBITDA increased 8% year-on-year, slower than the 15% USG increase. The difference does not by itself indicate deterioration—USG is a management-adjusted growth measure and reported sales are not an identical denominator—but it demonstrates that margin and cost dynamics deserve explicit examination.

Clean profit comparison: PAT before exceptional items rose 9% to ₹2,795 crore. Reported PAT of ₹2,796 crore was broadly flat because the prior-year base benefited from ₹273 crore of exceptional, tax-related gains. A superficial comparison of reported PAT would understate the growth of the ordinary business; ignoring the official exceptional-item bridge would overstate comparability.

For the first half of FY27, turnover totaled ₹35,255 crore, USG was 12%, UVG was 6% and PAT before exceptional items grew 9%. These are six-month observations and should not be entered as a single quarterly figure.

The board declared an interim dividend of ₹19/share. A declaration indicates a return-of-cash decision, but it is not evidence of a specific free-cash-flow figure in this quarter. Dividend yield requires a valid price observation and is not computed here.

Why it matters: Investors should reward sustainable growth in actual profit and cash generation more than a one-quarter acceleration in an adjusted top-line metric.

---

03 — Segment performance: where consumers are spending

SegmentQ2 FY27 USGRead-through
Home Care22%Double-digit volume growth, liquids and broad fabric/household strength
Beauty & Wellbeing16%Double-digit volume-led premium skin and hair expansion
Personal Care9%Skin-cleansing strength, oral-care growth more moderate
Foods9%Growth in nutrition and packaged foods, with low-single-digit segment UVG

Key takeaways

  • Home Care grew most rapidly.
  • Management described broad-based double-digit underlying volume momentum in fabric washing and household care, aided by liquids and portfolio pricing.
  • Premiumizing detergent formats may lift revenue per household, but relative price gaps matter when consumers face inflation.

Beauty & Wellbeing delivered 16% USG alongside premium skin and hair-care momentum. Innovation included new launches and the expansion of Simple and other premium offerings. Product novelty and premium shelf space may sustain growth, but advertising intensity and repeat purchase determine profit.

Personal Care showed 9% USG. Skin cleansing performed more strongly than the broader segment, while oral care was more moderate. This matters because legacy mass-market categories and premium innovation may need different volume and price assumptions.

Foods recorded 9% USG, with low-single-digit volume growth. Nutrition, packaged foods and coffee were areas of focus. Horlicks protein-powder expansion illustrates new-product adjacency; early traction is not a proven profit pool.

Investor implication: The portfolio is broad, but growth quality varies. Track volume and margin by segment, using consistent issuer definitions and avoiding unsupported segment-level profit figures.

---

04 — Distribution and strategy: the route to market is changing

Key takeaways

  • HUL's 'Winning in New India' strategy targets consumption, premiumization, category creation and new spaces.
  • The strategic rationale is to distribute more premium and new products through a network that already reaches many Indian households.

General trade. Management reported adding 30,000 outlets to distribution coverage during the quarter while increasing assortment across outlets. Added reach is valuable if it creates sustained sell-through; shipping more stock into the channel does not guarantee matching consumer demand.

Modern trade. The company described stepping up category-development asset deployment. This can support premium visibility, but newer investments require evidence of category contribution and retailer economics.

E-commerce and quick commerce. Technology-led service improvements and an omnichannel approach support emerging consumer behavior. The commercial opportunity includes availability, personalized assortment and brand discovery. The risk is higher fulfillment, promotional or channel margin costs.

Innovation. Examples include extensions in beauty, skin care, nutrition and household formats. The key is whether the innovations create incremental profitable demand, rather than cannibalizing an established product at higher marketing expense.

Why it matters: Distribution expansion and premiumization are believable sources of growth. They are not themselves a cash-flow forecast; evaluate same-store productivity, household penetration and advertising/retailer trade-offs.

---

05 — Management tone, investment, and capital allocation

Key takeaways

  • CEO Priya Nair emphasized volume-led consumer growth and more tailored distribution across channels, while CFO Niranjan Gupta noted 22.6% EBITDA margin within the company's guided range.
  • Management framed the portfolio strategy as reinvesting savings and operating capabilities into longer-term brand growth.

The crucial investor trade-off is between immediate margin expansion and defending brand quality or reaching emerging channels. Accepting temporary promotional costs may be economically rational if retention and lifetime profitability improve; repeated spending without measurable consumer gains would undermine that case.

Reported capital distribution. The ₹19/share interim dividend is a clear management action. It should not be used to impute undisclosed net debt, free cash flow or future buyback capacity. The research uses management's accepted quarterly disclosures; precise cash-flow and balance-sheet claims are left to the original detailed statements.

Supply chain and procurement. Management described continuity in key materials despite volatile geopolitical and input-price conditions. Resilience is strategically important, but reported profitability is the correct test of whether supply-chain benefits offset commodity inflation.

Q&A interpretation. The company spent substantial call time addressing consumer demand, innovation, margin and channels. Rather than assigning numerical scores to management's tone, the measurable response is whether underlying volumes remain healthy while EBITDA and clean PAT improve on comparable definitions.

Next-quarter checks: volume contribution across Home Care and Beauty, the gross margin and advertising bridge, Foods/Personal Care momentum, distribution productivity and the actual cash cost of new-channel expansion.

---

06 — Risk map and operating scenarios

RiskHow it affects profitObservable monitor
Commodity input inflationCan compress gross margin or force price increasesMaterial-cost trend, price/mix versus UVG
Category competitionForces advertising and price promotionsVolume growth and segment price actions
Premium innovation executionProduct launches may not retain customersRepeat purchase, segment sales and margins
Channel investmentNew routes to market can cost more to serveDistribution productivity, trade spend
Demand divergenceConsumption gains may favor only a few categoriesHome Care vs Foods/Personal Care UVG
Exceptional-item comparabilityReported PAT may misleadPAT before exceptional items and exact disclosed bridge

Key takeaways

  • Bull operating case: group UVG remains strong; Home Care and Beauty & Wellbeing lead sustainably; innovation and distribution enhance revenue without major margin sacrifice.
  • EBITDA and clean PAT begin to grow closer to underlying sales growth.

Base operating case: volume growth remains healthy but commodity and brand investment costs limit margin expansion. Reported EBITDA grows in mid-to-high single digits while management deploys resources into newer growth pools.

Bear operating case: price-sensitive consumers trade down, competitors retaliate, input costs rise and premium growth loses momentum. The company incurs ongoing channel investments without enough incremental gross profit.

These are operating descriptions, not unsupported numerical price targets. A scenario valuation would need current shares/price, comparable cash flow, a margin bridge and defensible forecasts.

Thesis breakers: sustained volume deceleration, repeated clean-PAT underperformance relative to sales, large marketing cost increases with weak retention and adverse commodity-price swings without pricing power.

---

07 — Practical watchlist, source register and glossary

Five observable questions for Q3 FY27:

  1. Does underlying volume growth hold near the Q2 7% reference, and is it still broad-based?
  2. Does Home Care sustain double-digit volume-led growth after a 22% USG Q2?
  3. Do premium beauty and hair segments sustain attractive mix without excessive promotional cost?
  4. Can EBITDA margin remain near the reported Q2 22.6% while costs rise and new products scale?
  5. Does PAT before exceptional items keep improving against the ₹2,795 crore Q2 baseline, without reliance on unusual tax effects?

Key takeaways

  • Capital and cash. Track actual working-capital movements, spending on new distribution and shareholder cash returns.
  • The ₹19/share interim dividend is historical board action, not a substitute for undisclosed quarter-specific free cash flow or valuation.

Previously accepted Sage PRO issuer sources

[1] HUL September Quarter 2026 results / investor presentation, dated 28 October 2026, document 79702. It provides the company turnover, USG/UVG, financial and segment disclosures. Original issuer link:

[2] HUL September Quarter 2026 earnings call, held 28 October 2026, document 72865. It supplies management's strategic and operating explanations. Original issuer link:

Both documents were accepted previously in Sage PRO and reused. No new extraction, re-review or re-scoring took place. The existing AI research score remains a separate product.

Simple note: This report uses company disclosures. Unsupported financial forecasts and valuations have been left out.

Glossary. USG: underlying sales growth excluding acquisition/disposal changes. UVG: underlying volume growth, including mix effects under HUL's definition. PAT before exceptional items: clean management-reported after-tax measure excluding specified exceptional effects. EBITDA: earnings before interest, taxes, depreciation and amortization, as reported by the issuer.

Bottom line: The strongest aspect of HUL's September quarter is its renewed, broad-based volume-led demand. The next investment test is whether that demand supports sustainable clean profit and cash returns after brand and channel investment.

SOURCE REFERENCES

Original disclosures and investor presentations

Original references are in the published manuscript below.

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.